Open AccessThe impact of topical mupirocin on peritoneal dialysis infection rates in Singapore General Hospital
Author(s) -
Christopher Thiam Seong Lim,
KokSeng Wong,
Marjorie Wai-Yin Foo
Publication year - 2005
Publication title -
nephrology dialysis transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.654
H-Index - 168
eISSN - 1460-2385
pISSN - 0931-0509
DOI - 10.1093/ndt/gfh860
Subject(s) - medicine , mupirocin , peritoneal dialysis , peritonitis , surgery , exit site , population , dialysis , intensive care medicine , methicillin resistant staphylococcus aureus , genetics , bacteria , biology , environmental health , staphylococcus aureus
Peritonitis and exit-site infections (ESI) are major causes of technique failure and morbidity in peritoneal dialysis (PD) patients. Topical mupirocin on the exit-site has been shown to reduce such complications and prolong life in PD. Since the year 2000, such an approach has been adopted for our new incident PD population. We now report the results of this new protocol. We also studied the effect of co-morbidity on peritonitis occurrence.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom